ES2422171T3 - Antígenos de carbunco y procedimientos de uso - Google Patents
Antígenos de carbunco y procedimientos de usoInfo
- Publication number
- ES2422171T3 ES2422171T3 ES05758632T ES05758632T ES2422171T3 ES 2422171 T3 ES2422171 T3 ES 2422171T3 ES 05758632 T ES05758632 T ES 05758632T ES 05758632 T ES05758632 T ES 05758632T ES 2422171 T3 ES2422171 T3 ES 2422171T3
- Authority
- ES
- Spain
- Prior art keywords
- anthrax
- subject
- immune response
- use procedures
- anthrax antigens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/07—Bacillus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Una composición en polvo seco adecuada para inducir una respuesta inmunitaria para el carbunco en un sujetocuando se administra a una superficie mucosa del sujeto, que comprende antígeno protector (PA) o un fragmentoinmunógeno del mismo y monofosforil lípido A (MPL), en la que parte del PA está presente como un péptidoconjugado con un péptido poli(ácido g-D-glutámico) (PGA), y en la que la respuesta inmunitaria puede mejorar oevitar al menos un síntoma de la enfermedad del carbunco.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54413004P | 2004-02-11 | 2004-02-11 | |
US54484804P | 2004-02-12 | 2004-02-12 | |
PCT/US2005/004678 WO2005086637A2 (en) | 2004-02-11 | 2005-02-11 | Anthrax antigens and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2422171T3 true ES2422171T3 (es) | 2013-09-09 |
Family
ID=34976060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES05758632T Active ES2422171T3 (es) | 2004-02-11 | 2005-02-11 | Antígenos de carbunco y procedimientos de uso |
Country Status (4)
Country | Link |
---|---|
US (1) | US8409590B2 (es) |
EP (1) | EP1735338B1 (es) |
ES (1) | ES2422171T3 (es) |
WO (1) | WO2005086637A2 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010075491A2 (en) * | 2008-12-24 | 2010-07-01 | University Of Rochester | Recombinant expression of self-folding neutralizing epitope-bearing subdomains of the respiratory syncytial virus attachment and fusion proteins |
CA2833420C (en) * | 2011-04-26 | 2019-09-03 | Rdd Pharma Ltd. | Oxymetazoline for the treatment of ano-rectal disorders |
US20140302084A1 (en) * | 2011-08-05 | 2014-10-09 | The University Of Chicago | Immunogenic protein conjugates and method for making and using the same |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4172126A (en) | 1976-11-08 | 1979-10-23 | Sankyo Company Limited | Method for the inactivation of microbial toxins and attenuation of vaccines |
US4436728A (en) | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
US4436727A (en) | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
RU1566532C (ru) | 1988-03-24 | 1995-12-20 | Всесоюзный государственный научно-контрольный институт ветпрепаратов | Способ изготовления вакцины против сибирской язвы животных |
US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
RU2115433C1 (ru) | 1992-08-28 | 1998-07-20 | Научно-исследовательский институт микробиологии МО РФ | Вакцина сибиреязвенная комбинированная |
RU2056861C1 (ru) | 1993-04-23 | 1996-03-27 | Всероссийский научно-исследовательский институт ветеринарной вирусологии и микробиологии | Ассоциированная вакцина против сибирской язвы и ящура и способ профилактики сибирской язвы и ящура |
US5674908A (en) | 1993-12-20 | 1997-10-07 | Life Technologies, Inc. | Highly packed polycationic ammonium, sulfonium and phosphonium lipids |
US5739118A (en) | 1994-04-01 | 1998-04-14 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
US6316006B1 (en) | 1994-11-23 | 2001-11-13 | The United States Of America As Represented By The Secretary Of The Army | Asporogenic B anthracis expression system |
RU2112544C1 (ru) | 1994-12-27 | 1998-06-10 | Всероссийский научно-исследовательский институт ветеринарной вирусологии и микробиологии | Вакцина против сибирской язвы и эмфизематозного карбункула живая ассоциированная и способ профилактики этих заболеваний |
US5962428A (en) | 1995-03-30 | 1999-10-05 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
RU2095409C1 (ru) | 1995-06-27 | 1997-11-10 | Всероссийский научно-исследовательский институт ветеринарной вирусологии и микробиологии | Способ изготовления вакцины против сибирской язвы животных |
RU2123532C1 (ru) | 1995-11-21 | 1998-12-20 | Ставропольский научно-исследовательский противочумный институт | Способ отбора культур сибиреязвенных вакцинных штаммов и изготовленных из них вакцин |
US6592872B1 (en) | 1996-09-17 | 2003-07-15 | The United States Of America As Represented By The Department Of Health And Human Services | Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein |
US6348450B1 (en) | 1997-08-13 | 2002-02-19 | The Uab Research Foundation | Noninvasive genetic immunization, expression products therefrom and uses thereof |
RU2142010C1 (ru) | 1997-09-15 | 1999-11-27 | Научно-исследовательский институт микробиологии Министерства обороны Российской Федерации | Способ глубинного культивирования сибиреязвенного вакцинного штамма сти-1 |
RU2142009C1 (ru) | 1997-09-15 | 1999-11-27 | Научно-исследовательский институт микробиологии Министерства обороны Российской Федерации | Способ поддержания сибиреязвенного вакцинного штамма сти-1 |
RU2141340C1 (ru) | 1998-04-21 | 1999-11-20 | Всероссийский научно-исследовательский институт ветеринарной вирусологии и микробиологии | Ассоциированная вакцина против сибирской язвы, анаэробной дизентерии и инфекционной энтеротоксемии овец и способ профилактики этих болезней |
RU2151798C1 (ru) | 1998-06-24 | 2000-06-27 | Научно-исследовательский институт микробиологии Министерства обороны Российской Федерации | Способ концентрирования споровых культур в производстве сибиреязвенных вакцинных препаратов |
WO2000002522A2 (en) | 1998-07-10 | 2000-01-20 | U.S. Medical Research Institute Of Infectious Diseases | Anthrax vaccine |
US6770479B1 (en) | 1998-07-10 | 2004-08-03 | The United States Of America As Represented By The Secretary Of The Army | Anthrax vaccine |
US6329156B1 (en) | 1999-03-22 | 2001-12-11 | The Regents Of The University Of California | Method for screening inhibitors of the toxicity of Bacillus anthracis |
RU2181294C2 (ru) | 1999-08-11 | 2002-04-20 | Научно-исследовательский институт микробиологии МО РФ | Способ получения сухой комбинированной сибиреязвенной вакцины |
FR2798291B1 (fr) | 1999-09-10 | 2005-01-14 | Pasteur Institut | Compositions acellulaires immunogenes et compositions acellulaires vaccinales contre bacillus anthracis |
US6602510B1 (en) | 2000-04-05 | 2003-08-05 | Epimmune Inc. | HLA class I A2 tumor associated antigen peptides and vaccine compositions |
EP1244687A4 (en) * | 1999-12-22 | 2005-06-15 | Univ Ohio State Res Found | METHODS OF PROTECTION AGAINST LETHAL INFECTION BY BACILLUS ANTHRACIS / i |
RU2181296C2 (ru) | 2000-07-13 | 2002-04-20 | ВНИИ ветеринарной вирусологии и микробиологии | Ассоциированная вакцина против сибирской язвы и оспы овец |
EP1351724B1 (en) | 2001-01-12 | 2005-08-17 | Becton, Dickinson and Company | Medicament respiratory delivery device, cartridge and method of making same |
RU2198921C2 (ru) | 2001-03-06 | 2003-02-20 | Центр военно-технических проблем биологической защиты Научно-исследовательского института микробиологии Министерства обороны Российской Федерации | Способ получения нативной споровой суспензии для приготовления сибиреязвенных вакцин |
RU2180917C1 (ru) | 2001-05-21 | 2002-03-27 | Федеральное государственное учреждение Российский научно-исследовательский противочумный институт "Микроб" | Штамм bacillus anthracis km90 - основа для генетического конструирования продуцентов сибиреязвенных антигенов |
WO2003049670A2 (en) | 2001-07-27 | 2003-06-19 | Immuno-Rx, Inc. | Adjuvant formulations for bacterial and virus vaccines and method of making same |
GB0126266D0 (en) | 2001-11-01 | 2002-01-02 | Microbiological Res Authority | Anthrax antigenic compositions |
RU2191599C1 (ru) | 2001-11-01 | 2002-10-27 | Караваев Юрий Дмитриевич | Ассоциированная вакцина для профилактики сибирской язвы и некробактериоза животных |
MXPA04005538A (es) | 2001-12-05 | 2005-06-08 | Bhatnagar Rakesh | Procedimiento para la preparacion de una vacuna no toxica contra el antrax. |
US20030118591A1 (en) | 2001-12-21 | 2003-06-26 | Joshua Levy | Passive hyperimmune antibody therapy in the treatment of anthrax |
US7354760B2 (en) * | 2001-12-26 | 2008-04-08 | University Of Central Florida Research Foundation, Inc. | Expression of protective antigens in transgenic chloroplasts |
US20040013688A1 (en) | 2002-07-03 | 2004-01-22 | Cambridge Scientific, Inc. | Vaccines to induce mucosal immunity |
US20070154494A1 (en) | 2003-02-13 | 2007-07-05 | Becton Dickinson And Company | Anthrax vaccines and delivery methods |
WO2005007804A2 (en) | 2003-04-10 | 2005-01-27 | President And Fellows Of Harvard College | Anthrax conjugate vaccine and antibodies |
AU2004252091B2 (en) | 2003-06-05 | 2010-06-10 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli |
EP1667634A4 (en) | 2003-07-30 | 2008-03-05 | Merck & Co Inc | ANTHRAX VACCINE |
GB0401036D0 (en) | 2004-01-17 | 2004-02-18 | Royal Holloway University Of L | Improvements in or relating to vaccination |
-
2005
- 2005-02-11 ES ES05758632T patent/ES2422171T3/es active Active
- 2005-02-11 EP EP05758632.3A patent/EP1735338B1/en not_active Not-in-force
- 2005-02-11 US US10/589,290 patent/US8409590B2/en not_active Expired - Fee Related
- 2005-02-11 WO PCT/US2005/004678 patent/WO2005086637A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20070202130A1 (en) | 2007-08-30 |
WO2005086637A2 (en) | 2005-09-22 |
WO2005086637A3 (en) | 2006-12-28 |
EP1735338A2 (en) | 2006-12-27 |
US8409590B2 (en) | 2013-04-02 |
EP1735338A4 (en) | 2008-04-16 |
EP1735338B1 (en) | 2013-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60239937D1 (de) | Hilfszusammensetzung für vakzinen, die über die schleimhaut oder durch injektion verabreicht werden | |
CY1116108T1 (el) | Εμβολιο ιου ερπητα ζωστηρα | |
NO20015073L (no) | Vaksiner | |
UY39192A (es) | Dispersión sólida, proceso para prepararla y forma de dosificación farmacéutica suministrable por vía oral que la comprende | |
AR052625A1 (es) | Nueva composicion | |
AR059203A1 (es) | Composiciones para uso vaginal | |
AR025750A1 (es) | Vacunas | |
ATE499113T1 (de) | Influenzavirus-impfstoffzusammensetzung | |
CO5700790A2 (es) | Composiciones de vacuna que comprenden una interleucina 18 y sistema de adyuvante de saponina | |
UY32041A (es) | Sistema de administración de drogas con contenido de progestina | |
AR064009A1 (es) | Metodo de inmunizacion contra los 4 serotipos del dengue | |
RU2013119946A (ru) | Быстрорастворяющаяся лекарственная форма пероральной вакцины, в которой используют крахмал | |
AR060580A1 (es) | Elastomeros de silicona que contienen antisepticos | |
CL2011003033A1 (es) | Uso de un lipopolisacarido de ochrobactrum intermedium lmg3306 o de una composición que lo comprende para el tratamiento y/o prevencion de sepsis o enfermedades infecciosas; procedimiento para la preparacion del lipopolisacárido; y composicion que comprende el lipopolisacarido. | |
ES2422171T3 (es) | Antígenos de carbunco y procedimientos de uso | |
ATE511855T1 (de) | Adjuvansformulierung zur scheimhaut-applikation | |
AR062659A1 (es) | Composicion de liberacion sostenida de levodopa y metodo para su uso | |
DK1024824T3 (da) | Dispergerende vaccinesammensætning i fast form til oral indgivelse | |
TW200637573A (en) | Peptide for delivery of mucosal vaccines | |
EP4248992A3 (en) | Foot-and-mouth disease vaccine | |
WO2008008541A8 (en) | Methods to elicit, enhance and sustain immune responses against mhc class-i restricted epitopes, for prophylactic or therapeutic purposes | |
WO2007034166A8 (en) | Adjuvanted vaccine | |
WO2006114680A8 (en) | Vaccine adjuvants | |
WO2010111586A3 (en) | Mucosal immunization | |
CO6511241A2 (es) | Régimen de inmunizaión por sensibilización-refuerzo heteróloga |